GS-100 dǝ recombinant AAV9 vector do NGLY1 gene kamye coding sǝdinma. Shi dǝye sha US Food and Drug Administration-a kuru European Medicine Agency (EMA) -a lan kurun dǝye orphan drug designation sǝdǝna. Shi kurun dǝye FDA-a dǝye banawa tadabe gana laa suro saa 2021 lan sǝdǝna kuru fast track designation saa kozǝna dǝn sǝdǝna.
#SCIENCE #Central Kanuri (Latin script) #CU
Read more at Clinical Trials Arena